NOVO.B.DK

319.1

+3.15%↑

GMAB.DK

1,984.5

+1.2%↑

HLUNB.DK

43.9

-0.18%↓

ZEAL.DK

549

+8.37%↑

NOVO.B.DK

319.1

+3.15%↑

GMAB.DK

1,984.5

+1.2%↑

HLUNB.DK

43.9

-0.18%↓

ZEAL.DK

549

+8.37%↑

NOVO.B.DK

319.1

+3.15%↑

GMAB.DK

1,984.5

+1.2%↑

HLUNB.DK

43.9

-0.18%↓

ZEAL.DK

549

+8.37%↑

NOVO.B.DK

319.1

+3.15%↑

GMAB.DK

1,984.5

+1.2%↑

HLUNB.DK

43.9

-0.18%↓

ZEAL.DK

549

+8.37%↑

NOVO.B.DK

319.1

+3.15%↑

GMAB.DK

1,984.5

+1.2%↑

HLUNB.DK

43.9

-0.18%↓

ZEAL.DK

549

+8.37%↑

Search

Coloplast A-S (Class B)

Ouvert

578.6 0.56

Résumé

Variation du prix de l'action

24h

Actuel

Min

569.8

Max

577.4

Chiffres clés

By Trading Economics

Revenu

-107M

805M

Ventes

28M

7B

P/E

Moyenne du Secteur

35.437

106.172

BPA

3.88

Rendement du dividende

4.01

Marge bénéficiaire

11.569

Employés

16,744

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.01%

2.31%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-8B

129B

Ouverture précédente

578.04

Clôture précédente

578.6

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

19 nov. 2025, 23:36 UTC

Actions en Tendance

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19 nov. 2025, 22:13 UTC

Résultats
Acquisitions, Fusions, Rachats

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19 nov. 2025, 21:55 UTC

Principaux Mouvements du Marché

Amgen Lung Cancer Drug Gets Full Approval From FDA

19 nov. 2025, 21:43 UTC

Acquisitions, Fusions, Rachats

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19 nov. 2025, 23:55 UTC

Market Talk

Gold Rises on Possible Investment Demand -- Market Talk

19 nov. 2025, 23:54 UTC

Market Talk

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19 nov. 2025, 23:47 UTC

Résultats

Lenovo Group 2Q EPS $2.52 >0992.HK

19 nov. 2025, 23:46 UTC

Résultats

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19 nov. 2025, 23:45 UTC

Résultats

Lenovo Group 2Q Rev $20.5B >0992.HK

19 nov. 2025, 23:42 UTC

Market Talk

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19 nov. 2025, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

19 nov. 2025, 23:41 UTC

Résultats

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19 nov. 2025, 23:41 UTC

Résultats

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19 nov. 2025, 23:40 UTC

Résultats

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19 nov. 2025, 22:55 UTC

Résultats

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19 nov. 2025, 22:41 UTC

Résultats

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19 nov. 2025, 22:30 UTC

Acquisitions, Fusions, Rachats

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19 nov. 2025, 22:30 UTC

Résultats

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19 nov. 2025, 22:30 UTC

Acquisitions, Fusions, Rachats

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19 nov. 2025, 22:27 UTC

Acquisitions, Fusions, Rachats

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19 nov. 2025, 22:08 UTC

Résultats

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19 nov. 2025, 22:00 UTC

Résultats

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19 nov. 2025, 21:58 UTC

Résultats
Acquisitions, Fusions, Rachats

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19 nov. 2025, 21:52 UTC

Résultats

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19 nov. 2025, 21:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

19 nov. 2025, 21:49 UTC

Market Talk
Résultats

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19 nov. 2025, 21:38 UTC

Résultats

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19 nov. 2025, 21:28 UTC

Acquisitions, Fusions, Rachats

Palo Alto Networks to Buy Chronosphere for $3.35B

19 nov. 2025, 21:27 UTC

Acquisitions, Fusions, Rachats

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19 nov. 2025, 21:24 UTC

Résultats
Acquisitions, Fusions, Rachats

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat